Evidence map›Paper›PMID 14719848›Full record

ReviewObstetrics and gynecology clinics of North America2003

Antiviral and antiretroviral use in pregnancy.

Deborah M Money

Abstract readReview
In one paragraph

Review in Obstetrics and gynecology clinics of North America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. Influenza and pneumonia in pregnancy.Clinics in perinatology · 2005
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Deborah M MoneyDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Room 2H30, University of British Columbia, 4500 Oak Street, Vancouver, BC, V6H 3N1, Canada. dmoney@cw.bc.ca

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The history of antiviral and antiretroviral therapy is recent compared with many other medical therapies, including traditional antibiotics in pregnancy. There are few long-term data on which to base decisions of management in pregnancy. Accessing up-to-date information is critical to optimizing the safety of care for mothers and their infants. Exposure to medications in pregnancy can be toxic to a fetus in a gestational age-dependent manner. Determination of safe medications for pregnancy must take into consideration the need for certain medications and the possibility of inadvertent exposure in early pregnancy because of unplanned pregnancies. This article reviews the most commonly used antiviral and antiretroviral agents and places emphasis on the issues regarding use in pregnancy.

Indexed as

AnimalsAnti-Retroviral AgentsAntiviral AgentsEnzyme InhibitorsFemaleFoscarnetHIV InfectionsHumansInterferonsNeuraminidaseNucleosidesPregnancyPregnancy Complications, InfectiousProtease InhibitorsReverse Transcriptase InhibitorsAnti-Retroviral AgentsAntiviral AgentsEnzyme InhibitorsFoscarnetInterferonsNeuraminidaseNucleosidesProtease InhibitorsReverse Transcriptase Inhibitors

Identifiers

PMID14719848
PMCPMC7135277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.